Alvotech
- ALVO
- NASDAQ
- Drug Manufacturers - Specialty & Generic
- Biosimilar Development
- Biologics Manufacturing
$5.18
Today +3.08%Quote Oct 20, 2026, 02:54 PM UTC
−14.31%over the last month
Max drawdown −18.7%From 1-month high −18.2%3 months +42.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Alvotech
Alvotech, along with its various subsidiaries, is dedicated to the global development and manufacturing of biosimilar pharmaceuticals. Its product offerings span key therapeutic categories, encompassing autoimmune conditions, eye disorders, bone diseases, and cancer.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Employees
1,279
Market value
$1.62B
Quote Oct 20
Analyst target
$8.00
+54.3% from here
Floor
$4.67
9.9% below price
Resistance
$5.28
1.8% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ALVOPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free